financetom
Business
financetom
/
Business
/
US FDA approves GSK's combo meningococcal vaccine
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves GSK's combo meningococcal vaccine
Feb 14, 2025 7:01 PM

Feb 14 (Reuters) - The U.S. Food and Drug Administration

(FDA) approved GSK's combination vaccine to protect

against meningococcal infection for use in individuals aged 10

through 25 years, the company said on Saturday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved